Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dupilumab Phase 2 in Nasal Polyposis
NCT01920893Phase 2Completed
- Sponsor
- Sanofi
- Start
- Aug 2013
- Primary completion
- Nov 2014
- Modality
- Monoclonal Antibodies
- Countries
- 4
01
Overview
A Phase 2 trial of dupilumab in nasal polyps, sponsored by Sanofi. Started Aug 2013; status: completed.
02
Drugs
03
Conditions
nasal polyps
Beyond the preview
Go deeper on NCT01920893.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01920893.